stockrow
Saturday 7 November 2026
Export AIRS’s income statement to Excel — free account
AirSculpt Technologies, Inc.
AIRS Healthcare Medical Care Facilities
AirSculpt Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $151.8 million, down 15.8% from fiscal 2024.
- Revenue
- −8.71%
- EPS
- +33.3%
- Free cash flow
- −813.8%
- Total debt
- −90.4%
Quarter to September 2026, against a year earlier
0.55
0.89
−61.81%
Follow AIRS
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 6 Nov | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.79 | 1.29 | 2.11 | 0.86 | |
P/FCF ratio |
172.97 | 28.30 | 419.13 | 0.00 | |
P/Operating CF |
(47.29) | 37.29 | (257.30) | (36.74) | |
P/B ratio |
1.36 | 1.96 | 3.04 | 1.21 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.10 | 1.48 | 2.28 | 1.02 | |
EV/EBITDA |
137.01 | 285.52 | 0.00 | 0.00 | |
EV/Operating CF |
54.03 | 29.96 | 268.82 | (76.56) | |
EV/FCF |
241.75 | 32.35 | 451.69 | (59.56) | |
Quick Ratio |
0.36 | 0.57 | 0.61 | 0.62 | |
Current Ratio |
0.55 | 0.75 | 0.79 | 0.85 | |
Net Debt/EBITDA |
23.00 | 23.07 | 8.50 | 0.00 | |
Debt/Assets |
29.92% | 23.34% | 22.54% | 2.91% | |
Debt/Equity |
0.64 | 0.45 | 0.42 | 0.05 | |
Asset Turnover |
0.76 | 0.77 | 0.77 | 0.79 | |
Operating CF/Net income |
(1.97) | (2.20) | 1.11 | 0.00 | |
Capex/Depreciation |
(0.02) | (0.02) | (0.08) | (0.08) | |
Interest Coverage |
(0.68) | (1.50) | (0.03) | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
54.47% | 57.33% | 54.59% | 63.43% | |
Intangible Assets out of Total Assets |
0.63 | 0.61 | 0.60 | 0.61 | |
Share Based Compensation of Revenue |
(4.14%) | 1.42% | 2.13% | 3.43% | |
Graham Net Nets |
(0.70) | (0.34) | (0.19) | (0.46) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(9.60%) | (6.01%) | (3.90%) | (7.14%) | |
Free Cash Flow Yield |
0.58% | 3.53% | 0.24% | (1.99%) | |
Revenue per Share |
0.55 | 0.57 | 0.61 | 0.44 | |
Operating CF per Share |
(0.04) | 0.08 | (0.02) | (0.05) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.04) | 0.08 | (0.02) | (0.05) | |
Cash per Share |
0.14 | 0.24 | 0.27 | 0.21 | |
Shareholders Equity per Share |
1.45 | 1.44 | 1.48 | 1.46 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.45 | 1.44 | 1.48 | 1.46 | |
Free Cash Flow |
(2.59) | 5.22 | (1.47) | (3.70) | |
Working Capital |
(12.45) | (8.15) | (7.45) | (4.16) | |
Capital Expenditures |
(0.06) | (0.05) | (0.23) | (0.23) | |
Net Current Asset Value |
(84.14) | (67.41) | (60.95) | (58.79) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.01 | 0.01 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
2.28 | 2.67 | 2.08 | 2.60 | |
Average Payables |
5.81 | 5.80 | 5.30 | 5.44 | |
Average Assets |
200.04 | 197.63 | 195.82 | 186.85 | |
Average Common Equity |
82.95 | 88.80 | 97.99 | 94.02 |
Columns are period end dates · fundamentals updated 6 Nov 2026